Literature DB >> 16681758

Inactivation of Crk SH3 domain-binding guanine nucleotide-releasing factor (C3G) in cervical squamous cell carcinoma.

K Okino1, H Nagai, H Nakayama, D Doi, K Yoneyama, H Konishi, T Takeshita.   

Abstract

C3G, a Crk SH3 domain-binding guanine nucleotide-releasing factor functions as a guanine nucleotide exchange factor for Rap1. It is activated via the Crk adaptor protein and plays an important role in transducing signals from receptors on the cell surface to the nucleus via the Ras/Raf/MAPK signal transduction pathway. However, since the experimental data result in pleiotropic effects in the cascade manner, its precise function remains unclear. Here we examined the C3G expression in cervical squamous cell carcinomas and found a marked decrease in the expression of C3G in a high incidence of said samples. In addition, we also demonstrated frequent hypermethylation of C3G, which resulted in an inactivation mechanism of the gene. Clinical and pathologic data failed to show any relationship between the human papillomavirus infection and the down-regulation of C3G. These results indicate that inactivation of C3G by de novo methylation plays an important role in the development of cervical squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16681758     DOI: 10.1111/j.1525-1438.2006.00352.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  13 in total

1.  The Rap1 guanine nucleotide exchange factor C3G is required for preservation of larval muscle integrity in Drosophila melanogaster.

Authors:  Margret Shirinian; Milica Popovic; Caroline Grabbe; Gaurav Varshney; Fredrik Hugosson; Hans Bos; Holger Rehmann; Ruth H Palmer
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

2.  Development and characterization of a novel monoclonal antibody that recognizes an epitope in the central protein interaction domain of RapGEF1 (C3G).

Authors:  Zareena Begum; Ch Varalakshmi; Divya Sriram; Vegesna Radha
Journal:  Mol Biol Rep       Date:  2018-08-24       Impact factor: 2.316

3.  Regulation of P2X(7) gene transcription.

Authors:  Lingyin Zhou; Liping Luo; Xiaoping Qi; Xin Li; George I Gorodeski
Journal:  Purinergic Signal       Date:  2009-07-16       Impact factor: 3.765

4.  Reciprocal Negative Regulation between the Guanine Nucleotide Exchange Factor C3G and β-Catenin.

Authors:  Kunal Dayma; Anesh Ramadhas; Kotagiri Sasikumar; Vegesna Radha
Journal:  Genes Cancer       Date:  2012-09

5.  C3G overexpression in glomerular epithelial cells during anti-GBM-induced glomerulonephritis.

Authors:  Victoriya A Rufanova; Elias Lianos; Anna Alexanian; Elena Sorokina; Mukut Sharma; Ann McGinty; Andrey Sorokin
Journal:  Kidney Int       Date:  2008-09-10       Impact factor: 10.612

6.  Pressure activates colon cancer cell adhesion via paxillin phosphorylation, Crk, Cas, and Rac1.

Authors:  C Downey; D H Craig; M D Basson
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

7.  C3G shows regulated nucleocytoplasmic exchange and represses histone modifications associated with euchromatin.

Authors:  Dhruv Kumar Shakyawar; Kunal Dayma; Anesh Ramadhas; Chavvakula Varalakshmi; Vegesna Radha
Journal:  Mol Biol Cell       Date:  2017-02-01       Impact factor: 4.138

8.  C3G dynamically associates with nuclear speckles and regulates mRNA splicing.

Authors:  Dhruv Kumar Shakyawar; Bhattiprolu Muralikrishna; Vegesna Radha
Journal:  Mol Biol Cell       Date:  2018-05-01       Impact factor: 4.138

9.  Interaction of crk with Myosin-1c participates in fibronectin-induced cell spreading.

Authors:  Hyejin Oh; Hwan Kim; Baehyun Shin; Kun Ho Lee; Myeong Gu Yeo; Woo Keun Song
Journal:  Int J Biol Sci       Date:  2013-08-15       Impact factor: 6.580

10.  C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38α activation, while it impairs tumor growth through p38α-independent mechanisms.

Authors:  Neibla Priego; María Arechederra; Celia Sequera; Paloma Bragado; Ana Vázquez-Carballo; Álvaro Gutiérrez-Uzquiza; Víctor Martín-Granado; Juan José Ventura; Marcelo G Kazanietz; Carmen Guerrero; Almudena Porras
Journal:  Oncotarget       Date:  2016-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.